Quantum BioPharma Ltd.

NASDAQ: QNTM · Real-Time Price · USD
20.68
-1.77 (-7.88%)
At close: Aug 18, 2025, 3:59 PM
20.83
0.73%
After-hours: Aug 18, 2025, 07:09 PM EDT

Quantum BioPharma Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
467.02K n/a n/a n/a
Gross Profit
n/a n/a n/a n/a
Operating Income
-16.14M -23.79M -27.43M -33.74M
Interest Income
572.89K 786.36K 367.74K 1.29K
Pretax Income
-14.92M -18.23M -26.7M -33.94M
Net Income
-14.2M -17.9M -23.61M -35.29M
Selling & General & Admin
9.31M 13.2M 15.98M 23.37M
Research & Development
6.08M 3.86M 6.91M 6.33M
Other Expenses
742.8K 6.73M 4.54M 4.05M
Operating Expenses
16.14M 23.79M 27.43M 33.74M
Interest Expense
47.58K 299.00 48.82K 69.4K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
16.14M 23.79M 27.43M 33.74M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
1.14M 609.06K 595.88K 537.62K
Shares Outstanding (Diluted)
1.14M 609.06K 595.88K 537.62K
EPS (Basic)
-12.49 -29.39 -39.62 -65.63
EPS (Diluted)
-12.49 -29.39 -39.62 -65.63
EBITDA
-13.69M -15.72M -22.12M -29.82M
EBIT
-14.87M -18.23M -26.65M -33.87M
Depreciation & Amortization
490.57K 2.51M 4.53M 4.05M